Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy – CORRECTION
April 10, 2026 16:09 ET | Source: Mesoblast Limited Working with Parent…
Dr. Teresa Montagut Appointed as Clinical Development and Medical Affairs Head at Mesoblast
March 11, 2026 19:21 ET | Source: Mesoblast Limited NEW YORK, March…
Mesoblast Announces Changes to Board of Directors’ Leadership Roles
January 01, 2026 18:02 ET | Source: Mesoblast Limited NEW YORK, Jan.…
Mesoblast Retires Senior Debt with Non-Dilutive, Lower Cost, Five-Year Credit Line
December 29, 2025 18:57 ET | Source: Mesoblast Limited Mesoblast has option…
